VOR BIOPHARMA INC (VOR)
US9290331084 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -112.46M | -117.86M | -92.09M | -68.90M | -43.34M | |||
| Depreciation Amortization | 3.56M | 3.49M | 2.53M | 1.43M | 610.00K | |||
| Change In Working Capital | -3.59M | 650.00K | -12.69M | -9.01M | 4.32M | |||
| Other non cash items | 12.87M | 13.43M | 17.12M | 7.33M | 2.12M | |||
| OPERATING CASH FLOW | -99.62M | -100.29M | -85.14M | -69.14M | -36.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -266.00K | -1.07M | -8.46M | -3.89M | -4.16M | |||
| Other Investing Activity | 107.53M | 72.08M | -85.63M | -87.76M | N/A | |||
| INVESTING CASH FLOW | 107.27M | 71.01M | -94.09M | -91.65M | -4.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 131.00K | 3.65M | 117.14M | 235.13M | 82.53M | |||
| Other Financing Activity | 3.00K | -717.00K | 0.00 | -2.22M | N/A | |||
| FINANCING CASH FLOW | 134.00K | 2.94M | 117.14M | 232.91M | 82.53M | |||
| CHANGE IN CASH | 7.78M | -26.35M | -62.09M | 72.12M | 42.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -99.62M | -100.29M | -85.14M | -69.14M | -36.29M | |||
| Capital Expenditure | -266.00K | -1.07M | -8.46M | -3.89M | -4.16M | |||
| FREE CASH FLOW | -99.89M | -101.36M | -93.60M | -73.03M | -40.45M | |||
All data in USD